Pediatric emergency medical services in privately insured patients: A 10-year national claims analysis

Lucas Oliveira J E Silva1, Jana L Anderson2, M Fernanda Bellolio3

  • 1Department of Emergency Medicine, Mayo Clinic, Rochester, MN, United States of America; Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Brazil.

Insights

Pediatric Emergency Medical Service (EMS) transports show a rise in mental health and neurologic conditions, with a decrease in trauma cases. Most children required emergency department care, highlighting evolving pediatric emergency transport needs.

Area of Science:

  • Pediatric Emergency Medicine
  • Health Services Research
  • Public Health

Background:

  • Emergency Medical Service (EMS) transports are crucial for pediatric emergency care.
  • Understanding trends in pediatric EMS transports is vital for resource allocation and policy development.
  • National claims data offers a broad perspective on pediatric emergency care utilization.

Purpose of the Study:

  • To characterize pediatric Emergency Medical Service (EMS) transports to the Emergency Department (ED) using a national claims database.
  • To identify trends in diagnosis categories and interventions for pediatric EMS transports.
  • To assess the acuity of pediatric patients transported by EMS.

Main Methods:

  • Utilized the OptumLabs Data Warehouse from 2007-2016, including children aged 18 and younger transported by EMS.
  • Categorized diagnoses using ICD-9 and ICD-10 codes; extracted interventions via procedure codes.
  • Assessed ED visit severity using the Minnesota Algorithm.

Main Results:

  • Over 10 years, 239,243 children were transported; trauma was most frequent in children aged 5 and older.
  • Neurologic and mental disorder transports significantly increased, particularly in adolescents (14-18 years).
  • Trauma transport rates decreased across all age groups, while 15.6% received interventions and 15.8% were admitted.

Conclusions:

  • Trauma remains a primary reason for pediatric EMS transport in older children.
  • Significant increases in mental health and neurologic transports, alongside decreasing trauma rates, necessitate policy and EMS adjustments.
  • The majority of pediatric EMS transports are for conditions requiring emergency department-level care.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
262
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
226
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
296
National Nursing Organizations I01:26

National Nursing Organizations I

Nursing organizations assume a significant role in consistently developing the nursing profession through education, research studies, establishing practice standards, and reforming health policies. Typically, nursing organizations operate at the regional, national, and international levels. For example, the International Council of Nurses (ICN) represents more than 28 million nurses worldwide. In contrast, the American Nurses Association (ANA) is a membership organization representing nurses...
3.1K
Testing a Claim about Mean: Known Population SD01:11

Testing a Claim about Mean: Known Population SD

A complete procedure of testing the hypothesis about a population mean is explained here.
Estimating a population mean requires the samples to be distributed normally. The data should be collected from the randomly selected samples having no sampling bias. The sample size needed to be higher than 30, and most importantly, the population standard deviation should be already known.
In most realistic situations, the population standard deviation is often unknown, but in rare circumstances, when it...
3.3K